Skip to content

The clinical study of Wenzhong Yangyuan moxibustion to treat late-onset hypogonadism

Wenzhong Yangyuan therapy(WYT) for late-onset hypogonadism(LOH): a randomized controlled trial protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006689
Enrollment
Unknown
Registered
2022-10-07
Start date
2022-10-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Late-onset hypogonadism

Interventions

trial group:acupuncture and moxibustion
control group:acupuncture

Sponsors

Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital(Shanghai Institute of Acupuncture, Moxibustion and Me
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for age-related testosterone deficiency; (2) Age = 40 years and= 70 years, male (3) The duration of the illness ranges from 6 months to 60 months; (4) Understand, consent to participate in this study, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1)Patients with endocrine diseases such as diabetes mellitus and thyroid dysfunction; (2) Patients with severe vision, hearing impairment, sensory aphasia, psychiatric symptoms, etc., which affect functional evaluation (3) Patients with severe internal diseases such as heart, liver and kidney, and tumors (4) Patients with conditions that may affect their hormone levels or recent use of medications that may affect hormone levels;

Design outcomes

Primary

MeasureTime frame
teststerone;ADAM scores;SILOH scores;AMS scores;PADAM scores;

Secondary

MeasureTime frame
prostate volume;LH;PSA;FSH;

Countries

China

Contacts

Public ContactShimin LIu
liusmin@sina.com13020291645

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026